Journal of Commercial Biotechnology
· Australia · Est. 1969
Aims & Scope
The Journal of Commercial Biotechnology is a definitive international quarterly publication for life sciences business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of business strategy and management, improve and advance their product development, or those who want to keep up-to-date with current issues and industry trends. Our focus is on the life science industries, e.g. biopharma (biotechnology & pharmaceuticals, MedTech and digital health; and on food and agricultural products and services to improve organisms. Each issue publishes peer-reviewed, authoritative, cutting-edge articles and perspectives (“Biotechnology Industry Perspectives”; and ”Bioentrepreneurship University Insights”) written by the leading practitioners and researchers in the field. We publish both submitted and solicited articles (including special editions), addressing topics such as: Management, Leadership, and collaborative teams Commercialization, Marketing, and Innovation strategies and best practices Entrepreneurship, including education Policy Finance & transactions associated with founding, building, partnering and exiting Law, Intellectual Property, Regulation, Reimbursement Bioethics The Journal of Commercial Biotechnology is a unique forum for all those involved in life sciences commercialization to present, share, and explore new ideas, latest thinking and best practices, making it an indispensable guide for those developing projects and careers within this fast-moving and diverse field.
General Information
Submission Info
Ethics & Quality
Think.Check.Submit Compliance
A twelfth criterion — whether APC fees are clearly disclosed — is not scored here; it is left out of the total rather than counted as a failure. Publication charges appear in the metrics card above.
Based on the Think.Check.Submit framework by DOAJ, COPE & OASPA. All data from verified open sources.
Publication & Citation Trend
Source: OpenAlex · Each year’s green bar = citations earned by that year’s papers, counted to date — so recent years look lower simply because their papers haven’t had time to be cited yet.
SJR Quartile by Discipline
Scimago ranks this journal separately in each subject category — its quartile can differ by discipline.
Subject Classification
Scopus Categories
Research Topics (OpenAlex)
Frequently asked questions about Journal of Commercial Biotechnology
Is Journal of Commercial Biotechnology a predatory journal?
PubScope has no integrity flags on record for Journal of Commercial Biotechnology: it is indexed in Scopus, and is not on DOAJ's withdrawn list. Indexing is a transparency signal, not a guarantee — always confirm fit and policies before submitting.
What is the impact factor of Journal of Commercial Biotechnology?
Journal of Commercial Biotechnology is not in the Web of Science Core Collection, so it has no official Clarivate Journal Impact Factor. Its SCImago SJR score is 0.178.
Is Journal of Commercial Biotechnology indexed in Scopus and Web of Science?
Journal of Commercial Biotechnology is indexed in Scopus.
What is the aims and scope of Journal of Commercial Biotechnology?
The Journal of Commercial Biotechnology is a definitive international quarterly publication for life sciences business professionals. The Journal is designed specifically for those professionals who need to enhance their knowledge of business strategy and management, improve and advance their product development, or those who want to keep up-to-date with current issues and industry trends. Our focus is on the life science industries, e.g. biopharma (biotechnology & pharmaceuticals, MedTech and digital health; and on food and agricultural products and services to improve organisms. Each issue p
You May Also Like
See all →Data updated: 2026-05-22 · Sources: SJR, DOAJ, OpenAlex, WoS, Crossref